The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
June 30th 2025
FDA removes REMS for CAR T-cell therapies, enhancing patient access while ensuring safety in cancer treatment.
Duke Researchers Identify a Relationship Between Prostate Cancer Recurrence and Lipid Levels
October 11th 2014In a retrospective study, investigators found that increases in total cholesterol and triglycerides were associated with an increased risk of biochemical recurrence in prostate cancer.
Read More
Pregnancy Hormone Research May Lead to New Methods of Breast Cancer Prevention
October 7th 2014Researchers in Finland are learning more about how hormones influence the risk of developing breast cancer, which may lead to a hormone-based treatment to reduce the risk of developing cancer later in life.
Read More